Long-term Benralizumab Safe and Effective for Severe Asthma

Share this post

The drug is safe for severe uncontrolled asthma over 2 years, and reduces exacerbations in vast majority of patients, according to results from the 1-year BORA extension study.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply